Microsomal epoxide hydrolase deletion enhances tyrosine hydroxylase phosphorylation in mice after MPTP treatment
- 23 May 2008
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 86 (12), 2792-2801
- https://doi.org/10.1002/jnr.21725
Abstract
Parkinson's disease (PD) is the most prevalent neurodegenerative movement disorder. Epidemiological studies have suggested most cases of PD are linked to environmental risk factors. Microsomal epoxide hydrolase (mEH) is a conserved enzyme that catalyzes hydrolysis of a large number of epoxide intermediates such as drugs and epoxides of environmental toxins. We hypothesize that changes in mEH are involved in the pathogenesis of PD by modulating the vulnerability of dopaminergic neurons to environmental stress. Herein we reported that acute treatment with the neurotoxin MPTP (1‐methyl‐4‐phemyl‐1,2,3,6‐tetrahydropyridine) markedly increased the mEH immunoreactivity in the nigrostriatal system of C57BL/6 mice. Next, mEH knockout (KO) mice were used, and we found that tyrosine hydroxylase (TH)‐positive cell loss was significantly lower in the substantia nigra of mEH KO mice compared with wild‐type (WT) mice after MPTP treatment. The mean dopamine turnover ratios were significantly increased in MPTP‐treated mEH KO mice compared with WT. In addition, TH is the rate‐limiting enzyme for dopamine biosynthesis, and its activity is mainly regulated by TH phosphorylation at Ser‐31 (pSer31) and Ser‐40 (pSer40). Double immunofluorescence showed that both pSer31 and pSer40 are completely colocalized in total TH‐positive cells. However, immunoblotting confirmed that there was a significantly higher level of pSer31 in mEH‐KO mice when compared with WT mice after MPTP, and no marked differences among TH and its phosphorylation levels occurred after saline injection. These data suggested that mEH deficiency facilitates TH phosphorylation in the nigrostriatal dopamine system, which may be associated with an increased resistance of dopaminergic neurons to environmental toxins.Keywords
This publication has 41 references indexed in Scilit:
- Cytochrome P4501A1 and Microsomal Epoxide Hydrolase Gene Polymorphisms: Gene–Environment Interaction and Risk of Prostate CancerDNA and Cell Biology, 2007
- Protocol for the MPTP mouse model of Parkinson's diseaseNature Protocols, 2007
- Astrocyte activation and reactive gliosisGlia, 2005
- Effects of Substitution at Serine 40 of Tyrosine Hydroxylase on Catecholamine BindingBiochemistry, 2001
- GSTM1 and mEPHX Polymorphisms in Parkinson's Disease and Age of OnsetBiochemical and Biophysical Research Communications, 2000
- N-methyl-(R)-salsolinol and its relevance to Parkinson's diseaseThe Lancet, 1998
- Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in manJournal of Neural Transmission, 1996
- Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactionsPharmacogenetics, 1994
- Human peripheral lymphocytes as indicators of microsomal epoxide hydrolase activity in liver and lungPharmacogenetics, 1993
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983